Xiaoyao San Alleviates Depression‐Associated Dry Eye via the LncRNA‐Nespas/TAK1 Axis by Suppressing Central and Peripheral Inflammation
Advanced Biology · 2026
DOI: 10.1002/adbi.70158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, 2026. Verfasst von Jun Peng und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Dry Eye Syndromes, MAP Kinase Kinase Kinases, Drugs, Chinese Herbal. Die Arbeit nennt 73 Literaturangaben. Gefördert von: Hunan Provincial Health and Family Planning Commission General Project, Natural Science Foundation of Hunan Province, National Natural Science Foundation Program.
Themen: Depression
Abstract (Originalsprache)
Depression commonly manifests alongside dry eye disease (DED), and effective targeted treatments for this comorbid disorder are currently limited. Xiaoyao San (XYP), a traditional Chinese herbal formulation, is widely applied for the management of mood disturbances. This study explored the therapeutic effects and underlying molecular mechanism of XYP against depression‐associated DED. A mouse model of comorbid depression and DED was generated by exposing animals to chronic unpredictable mild stress in a low‐humidity environment. XYP notably ameliorated depressive‐like phenotypes, restored tear secretion, and relieved corneal injury ( p < 0.05 or p < 0.01). Molecular analyses revealed that XYP suppressed TAK1 expression and p38/NF‐κB phosphorylation, and strengthened the interaction between lncRNA‐Nespas and TAK1 in vivo. These regulatory effects were recapitulated in LPS/ATP‐challenged BV2 microglia and hyperosmotic stress‐exposed human corneal epithelial cells. Of note, genetic silencing of lncRNA‐Nespas significantly reversed the anti‐inflammatory actions of XYP. Collectively, XYP alleviates depression‐associated DED by targeting the lncRNA‐Nespas/TAK1 signaling axis, which suppresses inflammation in both the central nervous system and ocular tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China.
- The First Hospital of Hunan University of Chinese Medicine, Changsha, China.
- College of Pharmacy, Ningxia Medical University, Yinchuan, China.
- College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
- College of Medicine, Hunan University of Chinese Medicine, Changsha, China.
ORCID-Profile: Hongping Long, Jian Shi, Hanqing Wang
Förderung
- Hunan Provincial Health and Family Planning Commission General Project
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation Program
- Leading Talent Cultivation Project in Science and Technology of Ningxia Hui Autonomous Region's
- Scientific Research Project of the Hunan Provincial Department of Education
Zitieren
APA
Peng, J., Li, J., Ni, Y., Gao, T., Liu, H., Wang, Y., Long, H., Shi, J., Wang, H., & Xie, M. (2026). Xiaoyao San Alleviates Depression‐Associated Dry Eye via the LncRNA‐Nespas/TAK1 Axis by Suppressing Central and Peripheral Inflammation. Advanced Biology. https://doi.org/10.1002/adbi.70158
Vancouver
Peng J, Li J, Ni Y, Gao T, Liu H, Wang Y, et al. Xiaoyao San Alleviates Depression‐Associated Dry Eye via the LncRNA‐Nespas/TAK1 Axis by Suppressing Central and Peripheral Inflammation. Advanced Biology. 2026. doi:10.1002/adbi.70158
BibTeX
@article{Peng2026,
author = {Peng, Jun and Li, Junyao and Ni, Ying and Gao, Tiantian and Liu, Huilin and Wang, Yajing and Long, Hongping and Shi, Jian and Wang, Hanqing and Xie, Mingxia},
title = {Xiaoyao San Alleviates Depression‐Associated Dry Eye via the LncRNA‐Nespas/TAK1 Axis by Suppressing Central and Peripheral Inflammation},
journal = {Advanced Biology},
year = {2026},
doi = {10.1002/adbi.70158}
}
EUVIMED